高级别胶质瘤术后配合替莫唑胺化疗的临床疗效与安全性
杨阳++姜德华[摘要] 目的 探讨替莫唑胺对高级别神经胶质瘤的临床治疗效果和安全性,为该类疾病的临床治疗提供方案参考。方法 选择2007年2月~2011年5月于徐州市中心医院收治的83例术后有残留灶的高级别神经胶质瘤患者,分为治疗组(42例)和对照组(41例),其中对照组给予外科治疗和常规外放疗,治疗组则在原有治疗基础上加用替莫唑胺进行化疗,评价两组的临床疗效。 结果 治疗组的近期总有效率为88.09%,对照组为60.97%,两组差异有统计学意义(P 0.05),但在化疗6个疗程时治疗组高于对照组,差异有统计学意义(P 0.05)。 结论 高级别神经胶质瘤术后使用替莫唑胺进行化疗,可提高临床有效率,改善患者的生存质量,且临床安全性和耐受性良好。
[关键词] 神经胶质瘤;替莫唑胺;生存期;预后治疗
[中图分类号] R739.4 [文献标识码] A [文章编号] 1673-7210(2014)11(c)-0047-04
Clinical efficacy and safety of Temozolomide for the postoperative high-grade gliomas
YANG Yang JIANG Dehua
Department of Neurosurgery, the Central Hospital of Xuzhou City Xuzhou Hospital Affiliated to Southeast University, Jiangsu Province, Xuzhou 221009, China
[Abstract] Objective To investigate the clinical effect and safety of Temozolomide for the postoperative high-grade gliomas,expected to provide a reference for the treatment of high-grade gliomas. Methods From February 2007 to May 2011, in the Central Hospital of Xuzhou City, 83 cases of patients with high-grade gliomas were selected and divided into treatment group (42 cases) and control group (41 cases) ......
您现在查看是摘要页,全文长 17195 字符。